Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03758066 · ClinicalTrials.gov registry record · NA

PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS

A NA study of HIV/AIDS, sponsored by Dimagi.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT03758066: Completed NA study of HIV/AIDS, sponsored by Dimagi.

NCT03758066 is a NA study of HIV/AIDS that has completed, run by Dimagi. The registered enrollment target is 65 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03758066, a NA study of HIV/AIDS, has completed, sponsored by Dimagi.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

While major advancements in medical technology over the past decade have significantly improved the life expectancy of persons infected with human immunodeficiency virus (HIV), HIV-positive youth today face new barriers to the treatment of HIV as a chronic, manageable illness. The mobile system proposed will help improve linkage to care through mobile technology support for the case management of youth living with HIV. Results of this project will determine the impact of this system on case management processes and outcomes and have implications for the care of youth living with other chronic, complex illnesses.

Primary Outcome

Comparison of average CD4 cell count (cells/mm\^3) between pre and post time points

Conditions Studied

HIV/AIDS

Interventions

  • DEVICE PlusCare

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2019-01-02
Est. Completion 2020-12-31
Phase NA
Dimagi

4 total trials

What the finished NCT03758066 record still lists

NCT03758066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which PlusCare is the first listed.

NCT03758066 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03758066 about?

NCT03758066 is a clinical study titled "PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS". While major advancements in medical technology over the past decade have significantly improved the life expectancy of persons infected with human immunodeficiency virus (HIV), HIV-positive youth today face new barriers to the treatment of HIV as a chronic, manageable illness. The mobile system prop...

What is the current status of trial NCT03758066?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-01-02. Estimated completion is 2020-12-31.

What conditions does trial NCT03758066 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT03758066?

The interventions under investigation include: PlusCare (DEVICE).

Who is sponsoring clinical trial NCT03758066?

This trial is sponsored by Dimagi, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03758066 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03758066's enrollment target sits among peer trials

65 41st of 61 higher than 21 of 61 other HIV/AIDS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03758066, the US trial registry maintained by the National Library of Medicine. NCT03758066 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.